COCP: Phase 1b Norovirus Challenge Study of CDI-988 to Commence in 1Q26
On November 14, 2025, Cocrystal Pharma, Inc. (COCP) announced financial results for the third quarter of 2025 and provided a business update. The...
185 Views
COCP: CDI-988 Showcased at Calicivirus Conference Direct Offering Raises Up to 13 Million
On September 12, 2025, Cocrystal Pharma, Inc. (COCP) announced a presentation on CDI-988 at the 9th International Calicivirus Conference. The...
242 Views
COCP: Norovirus Challenge Study to Initiate in 4Q25
On August 14, 2025, Cocrystal Pharma, Inc. (COCP) announced financial results for the second quarter of 2025 and provided a business update. The...
193 Views
COCP: Topline Results for High-Dose Cohort from Phase 1 Trial of CDI-988 Expected in 2Q25
On May 15, 2025, Cocrystal Pharma, Inc. (COCP) announced financial results for the first quarter of 2025 and provided a business update. Following...
330 Views
COCP: Norovirus Challenge Study Planned for 2025
On March 31, 2025, Cocrystal Pharma, Inc. (COCP) announced financial results for 2024 and provided a business update. Following the release of...
230 Views